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INTRODUCTION
Currently, there are few centers able to perform pulmon-
ary transplantation in Brazil.
1 The number of patients in
need of this procedure and their disease severity has
increased in recent years; however, the reduced number of
lung donors has resulted in a high mortality rate for patients
on the waiting list.
2 Some of these patients with exacerba-
tions of severe chronic pulmonary disease can be tempora-
rily supported by extracorporeal membrane oxygenation
systems, prolonging life until a donor lung is available for
transplantation.
3 Those patients who are mechanically
supported should receive the donated lungs with priority
and should be shifted forward on the waiting list.
4 In Brazil,
there are no extracorporeal membrane oxygenation centers
and, consequently, a prioritization system for patients
awaiting lung transplantation using extracorporeal mem-
brane oxygenation does not exist.
5 This report describes our
experience with an exacerbated severe hypoxemic patient
awaiting lung transplantation and using extracorporeal
membrane oxygenation in a tertiary center in Brazil.
CASE REPORT
An eighteen-year-old woman was admitted to the
respiratory intensive care unit of the Hospital das Clı ´nicas
de Sa ˜o Paulo, Brazil, with the diagnosis of pneumonia. The
chest X-ray is shown in Figure 1. She had a previous history
of advanced cystic fibrosis, was awaiting lung transplanta-
tion and was in the fifth position on the Sa ˜o Paulo State
waiting list. During the first day of her respiratory intensive
care unit stay, her status deteriorated, she was intubated,
and mechanical ventilation was started. In spite of the
ventilatory support, she developed severe hypoxemic and
hypercapnic respiratory failure (Table 1), with no signs
of hemodynamic compromise. Femoro-femoral venous-
venous extracorporeal membrane oxygenation support
was then initiated after ultrasound-guided placement of
the cannulas. Arterial blood gases improved, promoting a
comfortable spontaneous breathing pattern during mechan-
ical ventilation. Trivial anticoagulation with heparin was
started and titrated to a ratio of activated thromboplastin
time of 1.5–2.3. The clinical characteristics during the
patient’s respiratory intensive care unit stay are shown in
Table 1. The patient was maintained awake with a
Richmond Agitation Sedation Scale score ranging from -1
to 0.
The patient’s condition gradually improved, and daily
weaning from extracorporeal membrane oxygenation was
performed by zeroing the sweeper flow of the oxygenation
membrane. Our criteria for extracorporeal membrane
oxygenation removal are as follows: (1) the patient is awake
and comfortable throughout the test and (2) PaO2
$55 mmHg and PaCO2 #60 mmHg (or pH$7.30 in patients
with chronic hypercapnia) after one hour of ventilation with
PEEP #10 cm H2O, FIO2 #0.6 and a tidal volume #6 mL/
kg (or a driving pressure #12 cm H2O). We abort the test
when (1) the peripheral oxygen saturation is less than 85%,
(2) the patient presents clinical signs of dyspnea, or (3) the
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1659staff deems such an action to be necessary. The patient
remained on extracorporeal membrane oxygenation support
for 18 days with no adverse events, but she never tolerated
more than five minutes of the weaning test. After 18 days of
extracorporeal membrane oxygenation support, the patient
died.
DISCUSSION
In the case presented, before the initiation of extracor-
poreal membrane oxygenation support, we promoted an
extensive discussion between the respiratory intensive care
unit and transplantation teams in order to define the focus of
care. The background of the discussion was the absence, in
Brazil, of prioritization criteria for patients on the waiting list
for lung transplantation who require extracorporeal mem-
brane oxygenation support when weaning from extracorpor-
eal membrane oxygenation is considered difficult or
impossible. The final decision was to start extracorporeal
membraneoxygenationsupportandtofileaspecialrequestto
the Ministry of Health, asking to prioritize the patient on the
lung transplantation waiting list. Our expectation was that
with full intensive care support and antibiotics, the patient
would gradually improvetowarda clinical condition that was
sufficient to allow lung transplantation. In the meantime, our
request was analyzed by the Ministry of Health.
The extrapulmonary organ dysfunctions of the patient
quickly resolved; from a clinical standpoint, she was able to
undergo lung transplantation from the third day of her stay
in the respiratory intensive care unit. Despite her clinical
improvement, she remained completely dependent on
extracorporeal membrane oxygenation support (i.e., the
use of extracorporeal membrane oxygenation as a bridge to
lung transplantation). On the 17
th day of her stay in the
respiratory intensive care unit, the Ministry of Health
approved prioritization of the patient on the lung trans-
plantation list on an exceptional basis due to the circum-
stances. During this period, no transplant had been
performed from donors with the same blood type as the
patient. Unfortunately, the patient died on the 18
th day of
her stay in the respiratory intensive care unit.
In summary, we believe that our experience with this case
should motivate revision of the current legislation regulat-
ing lung transplants in Brazil, as well as the procurement,
conservation, and reconditioning of organ systems. The
scenario in which patients with exacerbations of chronic
severe pulmonary diseases will become dependent on the
support of extracorporeal devices will become frequent.
Should the clinical conditions allow, prioritization on the
waiting list for lung transplantation for these patients
should be carefully considered.
APPENDIX
The ECMO group comprises: Luciano Cesar Pontes Azevedo, Marcelo
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Table 1 - Clinical data and arterial blood gases.
Data Pre-ECMO Day 1 Day 2 Day 3 Day 4 Day 18
Mechanical ventilation
Ventilatory mode VCV
I PSV
I PSV
I PSV
I PSV
I PSV
I
Peak pressure (min – max) - cm H2O 28 - 28 28 - 33 28 - 33 28 - 28 26 - 28 24 - 24
PEEP (min – max) - cm H2O
£ 20 – 20 20 – 25 20 - 25 20 - 20 18 - 20 10 – 10
FIO2 (min – max)
¥ 0.6 – 0.7 0.7 – 0.7 0.6 – 0.7 0.6 – 0.6 0.6 – 0.6 0.6 – 0.6
Respiratory rate (min – max) - breaths/min 22 - 30 25 - 36 18 - 34 22 - 39 24 – 36 22 - 38
ECMO
J
Blood flow (min – max) - L/min 6.0 – 6.5 6.0 – 6.0 5.5 – 6.0 5.0 – 5.5 5.0 – 5.0 5.0 – 5.0
Sweeper flow (min – max) - L/min 6.0 – 10.0 6.0 – 6.0 4.0 – 6.0 2.5 – 4.0 2.5 – 2.5 2.5 – 2.5
FIO2 1.0 1.0 1.0 1.0 1.0 1.0
Routine blood gas
PaO2 - m m H g 4 25 06 27 45 5 8 1
PaCO2 - mm Hg 118 51 38 53 51 51
SBE - mEq/L * 1.8 6.1 -1.0 0.9 -0.8 2.1
pH 7.10 7.41 7.43 7.33 7.32 7.36
Patient data
RASS (min – max)
1 - 1-0 0-0 0–0 0–0 0–0 - 5-0
Lung injury score
" 4.00 4.00 4.00 3.75 3.75 3.00
Total SOFA score
1 1 0 9644 4
Respiratory SOFA 4 4 4 4 4 4
Cardiovascular SOFA 3 3 0 0 0 0
Hematological SOFA 1 1 1 0 0 0
Hepatic SOFA 1 0 0 0 0 0
Neurological SOFA 0 0 0 0 0 0
Renal SOFA 1 1 1 0 0 0
*SBE denotes standard base excess.
# RASS denotes Richmond agitation sedation score.
1SOFA denotes sequential organ failure assessment. This is a score to diagnose and quantify organ failure, which ranges from 0 to 24.
" The lung injury score is Murray `s score, which quantifies the severity of lung injury based on the respiratory compliance, PEEP, number of quadrants of
chest X-ray infiltrated and PaO2/FIO2 ratio.
I VCV denotes volume-controlled ventilation.
I PSV denotes pressure-support ventilation.
£ PEEP denotes positive end-expiratory pressure.
¥ FiO2 denotes inspiratory fraction of oxygen.
J ECMO denotes extracorporeal membrane oxygenation.
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